U.S. Department of Health and Human Services
NATIONAL INSTITUTES OF HEALTH NIH News
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) <
https://www.nichd.nih.gov/>
For Immediate Release: Tuesday, November 2, 2021
CONTACT: Linda Huynh or Robert Bock, 301-496-5133, <e-mail:nichdpress@xxxxxxxxxxxx>
MEDIA AVAILABILITY
NIH TO STUDY LONG-TERM EFFECTS OF COVID-19 IN PREGNANCY
Effort will follow up to 1,500 pregnant patients with COVID-19 and their offspring for four years
WHAT:
The National Institutes of Health will support a four-year follow-up study on the potential long-term effects of COVID-19 on women infected with SARS-CoV-2 during pregnancy. The study will also follow their offspring for any potential long-term effects.
The effort is part of NIH's Researching COVID to Enhance Recovery (RECOVER) Initiative <
https://recovercovid.org/>, which aims to understand why some individuals who have had COVID-19 don't fully recover or develop symptoms after recovery. Known as post-acute sequelae of SARS-CoV-2 infection (PASC), or more commonly as Long COVID, these conditions affect all ages. Long-term effects include fatigue, shortness of breath, difficulty concentrating, sleep disorders, fevers, anxiety and depression.
The current study will enroll some participants from an earlier study <
https://www.nichd.nih.gov/newsroom/news/012821-GRAVID> by the Maternal-Fetal Medicine Units (MFMU) Network, a 36-site research collaboration supported by NIH's Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Participants will be recruited from roughly 4,100 patients with asymptomatic and symptomatic SARS-CoV-2 infection during pregnancy who gave birth at MFMU Network hospitals. The research teams will assess patient symptoms periodically during the four-year period and evaluate their offspring for neurologic symptoms and cardiovascular conditions.
Researchers led by Torri Metz, M.D., of the University of Utah School of Medicine, will seek to understand what proportion of patients with COVID-19 in pregnancy are at risk for Long COVID, whether the severity of COVID-19 in pregnancy influences the likelihood of developing Long COVID, and how the proportion of patients who develop PASC after COVID-19 in pregnancy compares to that of non-pregnant women who develop PASC. Researchers hope the study findings will inform efforts to reduce the risk of Long COVID after pregnancy and to treat its symptoms.
WHO:
Monica Longo, M.D., project scientist, NICHD Maternal-Fetal Medicine Units Network, is available for comment.
About the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD): NICHD leads research and training to understand human development, improve reproductive health, enhance the lives of children and adolescents, and optimize abilities for all. For more information, visit <
https://www.nichd.nih.gov>.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit <
https://www.nih.gov>.
NIH...Turning Discovery into Health -- Registered, U.S. Patent and Trademark Office
###
This NIH News Release is available online at:
<
https://www.nih.gov/news-events/news-releases/nih-study-long-term-effects-covid-19-pregnancy>
To subscribe (or unsubscribe) from NIH News Release mailings, go to
<
http://service.govdelivery.com/service/subscribe.html?code=USNIH_1>.
If you subscribed via the NIH LISTSERV, go to <
https://list.nih.gov/cgi-bin/wa.exe?A0=nihpress>.
